BioInfra Life Science Inc. Logo

BioInfra Life Science Inc.

Biotech specializing in oncology diagnostics and R&D for cancer gene treatments.

266470 | KO

Overview

Corporate Details

ISIN(s):
KR7266470004
LEI:
Country:
South Korea
Address:
서울특별시 금천구 가산로9길 66 제1동 712호(가산동, 더리즌밸리지식산업센터), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioInfra Life Science Inc. is a global healthcare and biotechnology company specializing in oncology. The company focuses on cancer prevention and early detection through its proprietary Multi-Biomarker Blood Test, a technology developed over more than 15 years of research that analyzes a small blood sample to assess the risk for eight major cancers. In addition to diagnostics based on protein chip technology, BioInfra is engaged in the research and development of cancer gene treatments, localized drug delivery systems, and technologies to monitor metastasis and recurrence. Established in 2001, the company aims to improve cancer survival rates through innovative healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.7 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 22.4 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.6 KB
2025-03-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.5 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 10.3 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 908.7 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 91.1 KB
2025-02-28 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 14.7 KB
2024-12-20 00:00
Regulatory News Service
불성실공시법인지정 (공시불이행)
Korean 4.7 KB
2024-12-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 52.7 KB
2024-12-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-12 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 52.6 KB
2024-12-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-06 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.1 KB

Automate Your Workflow. Get a real-time feed of all BioInfra Life Science Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioInfra Life Science Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioInfra Life Science Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Candel Therapeutics, Inc. Logo
Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.
United States of America
CADL
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel
CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany
27N0
Canopy Growth Corp Logo
Produces diverse cannabis products for medical and recreational markets globally.
United States of America
CGC
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany
HIGH
CAPRICOR THERAPEUTICS, INC. Logo
Develops cell and exosome-based therapeutics for rare diseases like Duchenne muscular dystrophy.
United States of America
CAPR
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea
214370
Caribou Biosciences, Inc. Logo
Uses CRISPR genome editing to create off-the-shelf CAR-T cell therapies for cancer.
United States of America
CRBU
Carisma Therapeutics Inc. Logo
Developing engineered macrophage (CAR-M) therapies for solid tumors and autoimmune diseases.
United States of America
CARM
Cartesian Therapeutics, Inc. Logo
Pioneering mRNA-engineered cell therapies to treat autoimmune diseases.
United States of America
RNAC

Talk to a Data Expert

Have a question? We'll get back to you promptly.